TFX
Teleflex Incorporated
TFX offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over TFX overall, supported by stronger modeled upside and lower modeled downside.
TFX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| Under pressure | |
| Under pressure |
TFX's profitability is currently healthy, but its revenue, cash flow and balance sheet are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
TFX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $153 | — |
| Current | 19x | $153 | — |
| Cheap | 28x | $227 | +48% |
| Fair | 34x | $279 | +82% |
| Expensive | 49x | $404 | +164% |
Historical ranges are pointers, not guarantees.
TFX has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
TFX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect TFX's earnings to grow and its profitability to improve, but its revenue to decline.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
UNH has the edge over TFX on the outlook, with more favorable revenue expectations.
TFX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.93 | +21% |
| Q3 2026 | $8.23 | +$15.52 |
| Q2 2026 | -$23.29 | -640% |
| Q1 2026 | -$22.80 | -806% |
| Q4 2025 | -$20.55 | -1489% |
| Q3 2025 | -$7.29 | -245% |
| Q2 2025 | $4.31 | -23% |
| Q1 2025 | $3.23 | -48% |
| Q4 2024 | $1.48 | -80% |
TFX has returned to profit: it earned $8.23 per share over the past year, after losing money the year before. Its recent earnings include one-off gains.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over TFX on earnings, with more consistent year-over-year improvement.
TFX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $567.8M | -38% |
| Q2 2026 | $570.3M | -27% |
| Q1 2026 | $548.3M | -22% |
| Q4 2025 | $569M | -28% |
| Q3 2025 | $913M | +19% |
| Q2 2025 | $780.9M | +4.2% |
| Q1 2025 | $700.7M | -5% |
| Q4 2024 | $795.4M | +2.8% |
TFX's revenue has slid since its 2025 peak: $568M last quarter, down 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | +63 points |
| Q2 2026 | 13% | -7.1 points |
| Q1 2026 | 3.7% | -14 points |
| Q4 2025 | 2.4% | +16 points |
| Q3 2025 | -45% | -64 points |
| Q2 2025 | 20% | +4.3 points |
| Q1 2025 | 18% | +19 points |
| Q4 2024 | -14% | -25 points |
TFX has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over TFX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
TFX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $74.7M | -4.1% |
| Q2 2026 | $77.9M | +$104.6M |
| Q1 2026 | $27.9M | -36% |
| Q4 2025 | -$92.9M | -154% |
| Q3 2025 | $77.8M | -63% |
| Q2 2025 | -$26.8M | -147% |
| Q1 2025 | $43.3M | -42% |
| Q4 2024 | $170.6M | +53% |
TFX still generates free cash flow, though less than at its 2024 peak: $87M over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over TFX on cash flow, with more consistent year-over-year improvement.
TFX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.7% | -2M shares |
| 1 year | -5.9% | -2.6M shares |
| 3 years | -12% | -5.7M shares |
| 5 years | -12% | -5.8M shares |
| Available history | -12% | -5.5M shares |
TFX has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $305M |
| Q2 2026 | $250M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $300M |
| Q4 2024 | — |
TFX spent $555M buying back its own shares over the past year, up 85% from the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
TFX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q4 2025 | 35.6x | High |
| Q3 2025 | 52.2x | High |
| Q2 2025 | 2.8x | Moderate |
| Q1 2025 | 2.9x | Moderate |
| Q4 2024 | 3.2x | Elevated |
| Q3 2024 | 2.5x | Moderate |
| Q2 2024 | 2.4x | Moderate |
TFX's net debt is about 3.6 years of its operating earnings (EBITDA), up from 2.9 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over TFX on leverage, with a lower net debt burden relative to earnings.
TFX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.4 | Neutral |
| Stochastic | 85.3 | Overbought |
TFX's weekly RSI is 68 (neutral) and its Stochastic is 85 (overbought).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
TFX PE vs Healthcare Sector
| Metric | TFX | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 26x | 28% below |
| PE % | 1 | 29 | 28 pts below |
TFX has the edge over UNH on valuation relative to its sector.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
TFX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $135.2 | 13% above |
| 20 week MA | $135.0 | 13% above |
| 50 week MA | $125.9 | 22% above |
| 100 week MA | $130.4 | 17% above |
| 200 week MA | $179.2 | 15% below |
TFX has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 15% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
TFX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $372.0 | $405.1 | +8.9% |
| 2021 | $405.1 | $327.4 | -19% |
| 2022 | $327.4 | $248.8 | -24% |
| 2023 | $248.8 | $249.3 | +0.2% |
| 2024 | $249.3 | $179.5 | -28% |
| 2025 | $179.5 | $122.8 | -32% |
| 2026 YTD | $122.8 | $153.2 | +25% |
TFX has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.